CompareMarketResearchRequest a sample
Home / Healthcare / Regenerative Medicine

Healthcare · Market report

Regenerative Medicine Market Size, Share and Forecast 2026-2036

The global regenerative medicine market is worth USD 31.6 bn in 2026 and is forecast to reach USD 107 bn by 2036, growing at a 13.0% CAGR. United States is the largest country market and Biomaterials and scaffolds is the largest by product segment.

USD 31.6 bnMarket size 2026
USD 107 bnForecast 2036
13.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global regenerative medicine market is worth USD 31.6 bn in 2026 and is forecast to reach USD 107 bn by 2036, growing at a 13.0% CAGR. United States is the largest country market and Biomaterials and scaffolds is the largest by product segment.

ScopeTissue-engineered products, stem-cell and platelet-based products, bone and cartilage grafts, skin substitutes and biomaterial scaffolds used to repair or replace damaged tissue, excluding gene and cell therapies.
IndustryHealthcare
Value 2025USD 28.0 bn
Value 2026USD 31.6 bn
Value 2036USD 107 bn
CAGR 2026-203613.0%
Volume 202645.0 million units
Volume 2036145 million units
Average price 2026USD 704 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Regenerative Medicine market size and forecast, 2026-2036

Exhibit 1The global regenerative medicine market is forecast to grow from USD 31.6 bn in 2026 to USD 107 bn by 2036, more than triplingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 13.0%
Regenerative Medicine market value, 2025 to 2036Market value by year. 2025: USD 28.0 bn; 2026: USD 31.6 bn; 2027: USD 35.8 bn; 2028: USD 40.4 bn; 2029: USD 45.7 bn; 2030: USD 51.6 bn; 2031: USD 58.3 bn; 2032: USD 65.9 bn; 2033: USD 74.4 bn; 2034: USD 84.1 bn; 2035: USD 95.0 bn; 2036: USD 107 bn. Compound annual growth rate 2026 to 2036: 13.0%.202531.6 bn202658.3 bn2031107 bn203613.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 31.6 bn
2027USD 35.8 bn
2028USD 40.4 bn
2029USD 45.7 bn
2030USD 51.6 bn
2031USD 58.3 bn
2032USD 65.9 bn
2033USD 74.4 bn
2034USD 84.1 bn
2035USD 95.0 bn
2036USD 107 bn

Regenerative Medicine market segmentation

By product

Exhibit 2Biomaterials and scaffolds is the largest segment by product, with 34.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Regenerative Medicine market share by product, 2026Share of 2026 revenue by product. Biomaterials and scaffolds: 34.0%; Tissue grafts and skin substitutes: 26.0%; Stem-cell and platelet-based products: 22.0%; Bone and cartilage repair: 18.0%.Biomaterials and scaffolds34.0%Tissue grafts and skin substitutes26.0%Stem-cell and platelet-based products22.0%Bone and cartilage repair18.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Biomaterials and scaffolds34.0%31.9%USD 10.8 bn12.3%
Tissue grafts and skin substitutes26.0%24.4%USD 8.2 bn12.3%
Stem-cell and platelet-based products22.0%26.9%USD 7.0 bn15.3%
Bone and cartilage repair18.0%16.9%USD 5.7 bn12.3%

By application

Exhibit 3Orthopedic and musculoskeletal adds the most revenue by application, growing from USD 12.0 bn in 2026 to USD 38.1 bn by 2036Estimated revenue in USD by application, 2026 and 2036 forecast
Regenerative Medicine market by application, 2026 and 2036Revenue by application in 2026 and 2036. Orthopedic and musculoskeletal: USD 12.0 bn in 2026, USD 38.1 bn in 2036, change +217%; Dental and other: USD 7.6 bn in 2026, USD 28.7 bn in 2036, change +278%; Wound and dermatology: USD 8.2 bn in 2026, USD 28.5 bn in 2036, change +247%; Cardiovascular: USD 3.8 bn in 2026, USD 12.0 bn in 2036, change +217%.20262036 forecastChangeOrthopedic and musculoskeletal+217%12.0 bn38.1 bnDental and other+278%7.6 bn28.7 bnWound and dermatology+247%8.2 bn28.5 bnCardiovascular+217%3.8 bn12.0 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Orthopedic and musculoskeletal38.0%35.5%USD 12.0 bn12.2%
Wound and dermatology26.0%26.5%USD 8.2 bn13.2%
Cardiovascular12.0%11.2%USD 3.8 bn12.2%
Dental and other24.0%26.8%USD 7.6 bn14.2%

By technology

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Cell therapy34.0%38.0%USD 10.8 bn14.3%
Gene therapy22.0%28.0%USD 7.0 bn15.8%
Tissue engineering24.0%18.0%USD 7.6 bn9.8%
Biomaterials20.0%16.0%USD 6.3 bn10.5%

By source

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Autologous42.0%40.0%USD 13.3 bn12.4%
Allogeneic44.0%46.0%USD 13.9 bn13.5%
Xenogeneic and synthetic14.0%14.0%USD 4.4 bn13.0%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals46.0%42.0%USD 14.6 bn12.0%
Specialty clinics30.0%30.0%USD 9.5 bn13.0%
Research and biotech24.0%28.0%USD 7.6 bn14.8%

Top 25 countries for regenerative medicine by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 86.5% of 2026 revenue and the 25 countries below together hold 96.0%.

Exhibit 4United States is the largest country market at USD 13.3 bn in 2026, and the three largest countries hold 59.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Regenerative Medicine market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 13.3 bn, 42.0%; China: USD 3.2 bn, 10.0%; Germany: USD 2.2 bn, 7.0%; Japan: USD 2.2 bn, 7.0%; United Kingdom: USD 1.3 bn, 4.0%; France: USD 1.3 bn, 4.0%; South Korea: USD 1.3 bn, 4.0%; Italy: USD 949 mn, 3.0%; India: USD 949 mn, 3.0%; Brazil: USD 791 mn, 2.5%.United States13.3 bn 42.0%China3.2 bn 10.0%Germany2.2 bn 7.0%Japan2.2 bn 7.0%United Kingdom1.3 bn 4.0%France1.3 bn 4.0%South Korea1.3 bn 4.0%Italy949 mn 3.0%India949 mn 3.0%Brazil791 mn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 13.3 bn42.0%USD 40.6 bn11.8%
2ChinaUSD 3.2 bn10.0%USD 14.9 bn16.8%
3GermanyUSD 2.2 bn7.0%USD 6.8 bn11.8%
4JapanUSD 2.2 bn7.0%USD 7.4 bn12.8%
5United KingdomUSD 1.3 bn4.0%USD 3.9 bn11.8%
6FranceUSD 1.3 bn4.0%USD 3.9 bn11.8%
7South KoreaUSD 1.3 bn4.0%USD 5.0 bn14.8%
8ItalyUSD 949 mn3.0%USD 2.9 bn11.8%
9IndiaUSD 949 mn3.0%USD 4.8 bn17.7%
10BrazilUSD 791 mn2.5%USD 2.9 bn13.9%
11AustraliaUSD 664 mn2.1%USD 2.1 bn12.1%
12SpainUSD 396 mn1.2%USD 1.2 bn12.1%
13CanadaUSD 291 mn0.9%USD 913 mn12.1%
14NetherlandsUSD 234 mn0.7%USD 730 mn12.1%
15SwitzerlandUSD 199 mn0.6%USD 623 mn12.1%
16IsraelUSD 174 mn0.6%USD 773 mn16.1%
17TaiwanUSD 155 mn0.5%USD 483 mn12.0%
18BelgiumUSD 139 mn0.4%USD 440 mn12.2%
19SingaporeUSD 127 mn0.4%USD 569 mn16.2%
20TurkeyUSD 117 mn0.4%USD 526 mn16.2%
21MexicoUSD 111 mn0.3%USD 483 mn15.9%
22SwedenUSD 104 mn0.3%USD 322 mn11.9%
23ThailandUSD 98 mn0.3%USD 430 mn15.9%
24PolandUSD 92 mn0.3%USD 408 mn16.1%
25AustriaUSD 89 mn0.3%USD 269 mn11.7%
Rest of worldUSD 1.3 bn4.0%USD 4.0 bn12.1%
Exhibit 5United States and China account for 52% of the USD 75.8 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Regenerative Medicine market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 31.6 bn. United States: +USD 27.3 bn; China: +USD 11.8 bn; Japan: +USD 5.2 bn; Germany: +USD 4.6 bn; India: +USD 3.9 bn; 20 other countries: +USD 20.3 bn; Rest of world: +USD 2.7 bn. Market value 2036: USD 107 bn.Market value 202631.6 bnUnited States+27.3 bnChina+11.8 bnJapan+5.2 bnGermany+4.6 bnIndia+3.9 bn20 other countries+20.3 bnRest of world+2.7 bnMarket value 2036107 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Medtronic
  • Integra LifeSciences
  • Smith and Nephew
  • Stryker
  • AbbVie
  • Organogenesis
  • Zimmer Biomet

Group 2: Regional and specialist players

  • Geistlich
  • MiMedx
  • Vericel
  • Bioventus
  • Orthofix
  • LifeNet Health
  • Anika Therapeutics
  • Kerecis
  • Tissue Regenix

Group 3: Emerging and niche players

  • CollPlant
  • Avita Medical
  • Mesoblast
  • Orthocell
  • Elutia
  • Cook Biotech

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the regenerative medicine market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 13.0% is calculated from the resulting values.

The market is divided by product, by application, by technology, by source, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the regenerative medicine market?

The global regenerative medicine market is estimated at USD 28.0 bn in 2025 and USD 31.6 bn in 2026.

How fast will the regenerative medicine market grow?

It is forecast to reach USD 107 bn by 2036, a compound annual growth rate of 13.0% from 2026, an increase of USD 75.8 bn.

Which country is the largest market for regenerative medicine?

United States is the largest market by revenue at USD 13.3 bn in 2026, 42.0% of the global total. The three largest countries together hold 59.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 17.7% a year from 2026 to 2036.

Which regenerative medicine segment is largest?

In the by product split, Biomaterials and scaffolds is the largest segment with 34.0% of 2026 revenue.

Who are the leading regenerative medicine companies?

Global leaders include Medtronic, Integra LifeSciences, Smith and Nephew, Stryker.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Rare Cardiovascular Disease Therapeutics Remote Patient Monitoring →

All Healthcare markets →

Request a sample